In vitro efficacy of topical ophthalmic antiseptics against SARS-CoV-2.

Felfeli, Tina; Kasloff, Samantha B; Krishnan, Jay; El-Defrawy, Sherif R; Mazzulli, Tony; Cutts, Todd A

Felfeli, Tina; Kasloff, Samantha B; Krishnan, Jay; El-Defrawy, Sherif R; Mazzulli, Tony; Cutts, Todd A.

Felfeli T; Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada.
Kasloff SB; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Krishnan J; Kensington Vision and Research Centre, Kensington Eye Institute, University of Toronto, Toronto, Ontario, Canada.
El-Defrawy SR; J.C. Wilt Infectious Diseases Research Centre, Public Health Agency of Canada Ontario Manitoba Saskatchewan Regional Office, Winnipeg, Manitoba, Canada.
Mazzulli T; Canadian Science Centre for Human and Animal Health, Winnipeg, Manitoba, Canada.
Cutts TA; J.C. Wilt Infectious Diseases Research Centre, Public Health Agency of Canada Ontario Manitoba Saskatchewan Regional Office, Winnipeg, Manitoba, Canada.

BMJ Open Ophthalmol ; 6(1): e000765, 2021.

Article in English | MEDLINE | ID: covidwho-2258931

Keywords

COVID-19; experimental & laboratory; infection; public health; tears

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: BMJ Open Ophthalmol Year: 2021 Document Type: Article Affiliation country: Bmjophth-2021-000765

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google